Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine

Cytotherapy

Volumn 14, Issue 5, 2012, Pages 555-562

  Wu, Xiuwen ^a   Ren, Jianan ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Adipose derived stromal cells; Bone marrow derived stromal cells; Fibrin glues; Mesenchymal stromal cells; Regenerative medicine

Indexed keywords

CADHERIN; FIBRIN GLUE; HISTOCOMPATIBILITY ANTIGEN; HYALURONIC ACID; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1;

ADIPOCYTE; ANTIGEN EXPRESSION; BONE DEFECT; BONE PROSTHESIS; BONE REMODELING; CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; CELL ADHESION; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; COST; CRYOPRECIPITATION; HEART FUNCTION; HUMAN; INTESTINE FISTULA; MESENCHYMAL STROMA CELL; MONONUCLEAR CELL; MUSCLE; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SAFETY; TENDON INJURY; TENDON RECONSTRUCTION; WOUND HEALING;

EID: 84859761242     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.638914     Document Type: Article

References (104)

1. Weissman I, Anderson D, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Ann Rev Cell Dev Biol. 2001;17:387-403.
2. Tapp H, Hanley EN Jr, Patt JC, Gruber HE. Adiposederived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med. 2009;234:1-9.
3. Charruyer A, Ghadially R. Stem cells and tissue-engineered skin. Skin Pharmacol Physiol. 2009;22:55-62.
4. Murasawa S, Asahara T. Cardiogenic potential of endothelial progenitor cells. Ther Adv Cardiovasc Dis. 2008;2:341-8.
5. Porada C, Zanjani E, Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther. 2006;1:365-9. cell
6. Schabort EJ, Myburgh KH, Wiehe JM, Torzewski J, Niesler CU. Potential myogenic stem cell populations: sources, plasticity, and application for cardiac repair. Stem Cells Dev. 2009;18:813-30.
7. Golestaneh N, Kokkinaki M, Pant D, Jiang J, DeStefano D, Fernandez-Bueno C, et al. Pluripotent stem cells derived from adult human testes. Stem Cells Dev. 2009;18:1115-26.
8. Dominici M, Le Blanc K, Mueller E, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defi ning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7.
9. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol. 2001; 189:54-63.
10. Delorme B, Chateauvieux S, Charbord P. The concept of mesenchymal stem cells. Regen Med. 2006;1:497-509.
11. Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK, Piao H, et al. Implantation of bone marrow mononuclear cells using injectable fi brin matrix enhances neovascularization in infarcted myocardium. Biomaterials. 2005;26:319-26.
12. Falanga V, Iwamoto S, Chartier M, Yufi t T, Butmarc J, Kouttab N, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fi brin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007;13:1299-312.
13. K albermatten DF, Kingham PJ, Mahay D, Mantovani C, Pettersson J, Raffoul W, et al. Fibrin matrix for suspension of regenerative cells in an artifi cial nerve conduit. J Plast Reconstr Aesthet Surg. 2008;61:669-75.
14. Vadala G, Di Martino A, Tirindelli MC, Denaro L, Denaro V. Use of autologous bone marrow cells concentrate enriched with platelet-rich fi brin on corticocancellous bone allograft for posterolateral multilevel cervical fusion. J Tissue Eng Regen Med. 2008;2:515-20.
15. Stacey DH, Hanson SE, Lahvis G, Gutowski KA, Masters KS. In vitro adipogenic differentiation of preadipocytes varies with differentiation stimulus, culture dimensionality, and scaffold composition. Tissue Eng Part A. 2009; 15:3389-99.
16. Girandon L, Kregar-Velikonja N, Boikov K, Barli A. In vitro models for adipose tissue engineering with adiposederived stem cells using different scaffolds of natural origin. Folia Biol (Praha) 2011;57:47-56.
17. Swartz, DD, Russel JA, Andreadis ST. Engineering of fi brin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol. 2005; 288:H1451-60.
18. Rosso F, Marino G, Giordano A, Barbarisi M, Parmeggiani D, Barbarisi A. Smart materials as scaffolds for tissue engineering. J Cell Physiol. 2005;203:465-70.
19. Le Guhennec L, Layrolle P, Daculsi G. A review of bioceramics and fi brin sealant. Eur Cell Mater. 2004;8:1-11.
20. Schantz JT, Teoh SH, Lim TC, Endres M, Lam CX, Hutmacher DW. Repair of calvarial defects with customized tissue-engineered bone grafts. I. Evaluation of osteogenesis in a three-dimensional culture system. Tissue Eng. 2003;9:S113-26.
21. Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, et al. Fibrin gel: advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2001;19:424-30.
22. Radosevich M, Goubran HI, Burnouf T. Fibrin sealant: scientifi c rationale, production methods, properties, and current clinical use. Vox Sang. 1997;72:133-43.
23. Siedentop KH, Harris DM, Sanchez B. Autologous fi brin tissue adhesive. Laryngoscope. 1985;95:1074-6.
24. Silver FH, Wang MC, Pins GD. Preparation and use of fi brin glue in surgery. Biomaterials. 1995;16:891-903.
25. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunological impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg. 2001; 233:88-96.
26. Liu G, Li Y, Sun J, Zhou H, Zhang W, Cui L, et al. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood-derived mesenchymal stem cells on partially demineralized bone matrix. Tissue Eng Part A. 2010;16: 971-82.
27. Guo X, Park H, Young S, Kretlow JD, van den Beucken JJ, Baggett LS, et al. Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater. 2010;6:39-47.
28. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, et al. Clinical transplantation of a tissueengineered airway. Lancet. 2008;372:2023-30.
29. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebocontrolled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54: 2277-86.
30. Satar B, Karahatay S, Kurt B, Ural AU, Safali M, Avcu F, et al. Repair of transected facial nerve with mesenchymal stromal cells: histopathologic evidence of superior outcome. Laryngoscope. 2009;119:2221-5.
31. Oh JY, Kim MK, Shin MS, Lee HJ, Ko JH, Wee WR, et al. The anti-infl ammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells. 2008;26:1047-55.
32. Ringd n O, Uzunel M, Sundberg B, L n nies L, Nava S, Gustafsson J, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia. 2007;21: 2271-6.
33. Kuo YR, Goto S, Shih HS, Wang FS, Lin CC, Wang CT, et al. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation. 2009;87:1769-77.
34. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fi brocytes defi ne a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1:71-81.
35. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 2003;196:245-50.
36. Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res. 2000;371:10-27.
37. Leong DT, Nah WK, Gupta A, Hutmacher DW, Woodruff MA. The osteogenic differentiation of adipose tissuederived precursor cells in a 3D scaffold/matrix environment. Curr Drug Discov Technol. 2008;5:319-27.
38. Cui G, Li J, Lei W, Bi L, Tang P, Liang Y, et al. The mechanical and biological properties of an injectable calcium phosphate cement-fi brin glue composite for bone regeneration. J Biomed Mater Res B Appl Biomater. 2010;92:377-85.
39. Ito K, Yamada Y, Naiki T, Ueda M. Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fi brin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res. 2006;17:579-86.
40. Liao HT, Chen CT, Chen CH, Chen JP, Tsai JC Combination of guided osteogenesis with autologous platelet-rich fi brin glue and mesenchymal stem cell 40 for mandibular reconstruction. J Trauma. 2011 70 228-37.
41. Awad HA, Butler DL, Boivin GP, Smith FN, Malaviya P, Huibregtse B, et al. Autologous mesenchymal stem cellmediated repair of tendon. Tissue Eng. 1999;5:267-77.
42. Ouyang HW, Goh JC, Thambyah A, Teoh SH, Lee EH. Knitted poly-lactide-co-glycolide scaffold loaded with bone marrow stromal cells in repair and regeneration of rabbit Achilles tendon. Tissue Eng. 2003;9:431-9.
43. Smith RK, Korda M, Blunn GW, Goodship AE. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superfi cial digital fl exor tendon as a potential novel treatment. Equine Vet J. 2003; 35:99-102.
44. Awad HA, Boivin GP, Dressler MR, Smith FN, Young RG, Butler DL. Repair of patellar tendon injuries using a cellcollagen composite. J Orthop Res. 2003;21:420-31.
45. Chong AK, Ang AD, Goh JC, Hui JH, Lim AY, Lee EH, et al. Bone marrow-derived mesenchymal stem cells infl uence early tendon-healing in a rabbit Achilles tendon model. J Bone Joint Surg Am. 2007;89:74-81.
46. Lacitignola L, Crovace A, Rossi G, Francioso E. Cell therapy for tendinitis, experimental and clinical report. Vet Res Commun. 2008;32:S33-8.
47. Crovace A, Lacitignola L, Francioso E, Rossi G. Histology and immunohistochemistry study of ovine tendon grafted with cBMSCs and BMMNCs after collagenase-induced tendinitis. Vet Comp Orthop Traumatol. 2008;21: 329-36.
48. Mandelbaum BR, Browne JE, Fu F, Micheli L, Mosely JB Jr, Erggelet C, et al. Articular cartilage lesions of the knee. Am J Sports Med. 1998;26:853-61.
49. Hui JH, Chen F, Thambyah A, Lee EH. Treatment of chondral lesions in advanced osteochondritis dissecans: a comparative study of the effi cacy of chondrocytes, mesenchymal stem cells, periosteal graft, and mosaicplasty (osteochondral autograft) in animal models. J Pediatr Orthop. 2004;24:427-33.
50. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994;76:579-92.
51. Cournil-Henrionnet C, Huselstein C, Wang Y, Galois L, Mainard D, Decot V, et al. Phenotypic analysis of cell surface markers and gene expression of human mesenchymal stem cells and chondrocytes during monolayer expansion. Biorheology. 2008;45:513-26.
52. Li WJ, Chiang H, Kuo TF, Lee HS, Jiang CC, Tuan RS. Evaluation of articular cartilage repair using biodegradable nanofi brous scaffolds in a swine model: a pilot study. J Tissue Eng Regen Med. 2009;3:1-10.
53. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarth Cart. 2002;10:199-206.
54. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant. 2004;13:595-600.
55. Wakitani S, Nawata M, Tensho K, Okabe T, Machida H, Ohgushi H. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in fi ve knees. J Tissue Eng Regen Med. 2007;1:74-9.
56. Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarth Cart. 2007;15:226-31.
57. Haleem AM, Singergy AA, Sabry D, Atta HM, Rashed LA, Chu CR, et al. The clinical use of human cultureexpanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fi brin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage. 2010;1:253-61.
58. Dragoo JL, Carlson G, McCormick F, Khan-Farooqi H, Zhu M, Zuk PA, et al. Healing full-thickness cartilage defects using adipose-derived stem cells. Tissue Eng. 2007;13:1615-21.
59. Guo HD, Wang HJ, Tan YZ, Wu JH. Transplantation of marrow-derived cardiac stem cells carried in fi brin improves cardiac function after myocardial infarction. Tissue Eng Part A. 2011;17:45-58.
60. Zhang G, Wang X, Wang Z, Zhang J, Suggs L. A PEGylated fi brin patch for mesenchymal stem cell delivery. Tissue Eng. 2006;12:9-19.
61. Zhang G, Hu Q, Braunlin EA, Suggs LJ, Zhang J. Enhancing effi cacy of stem cell transplantation to the heart with a PEGylated fi brin biomatrix. Tissue Eng Part A. 2008;14: 1025-36.
62. Taylor SJ, McDonald JW, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 from fi brin gels for spinal cord injury. J Control Rel. 2004;98:281-94.
63. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fi brin scaffold preserve cardiac function after myocardial infarction. Tissue Eng. 2004;10:403-9.
64. Bach TL, Barsigian C, Chalupowicz DG, Busler D, Yaen CH, Grant DS, et al. VE-Cadherin mediates endothelial cell capillary tube formation in fi brin and collagen gels. Exp Cell Res. 1998;238:324-34.
65. Zhang X, Wang H, Ma X, Adila A, Wang B, Liu F, et al. Preservation of the cardiac function in infarcted rat hearts by the transplantation of adipose-derived stem cells with injectable fi brin scaffolds. Exp Biol Med. 2010;235: 1505-15.
66. Mohanna PN, Terenghi G, Wiberg M. Composite PHBGGF conduit for long nerve gap repair: a long-term evaluation. Scand J Plast Reconstr Surg Hand Surg. 2005;39: 129-37.
67. Choi BH, Han SG, Kim SH, Zhu SJ, Huh JY, Jung JH, et al. Autologous fi brin glue in peripheral nerve regeneration in vivo. Microsurgery. 2005;25:495-9.
68. Kalbermatten DF, Pettersson J, Kingham PJ, Pierer G, Wiberg M, Terenghi G. New fi brin conduit for peripheral nerve repair. J Reconstr Microsurg. 2009;25:27-33.
69. Tohill M, Mantovani C, Wiberg M, Terenghi G. Rat bone marrow mesenchymal stem cells express glial markers and stimulate nerve regeneration. Neurosci Lett. 2004;362:200-3.
70. Caddick J, Kingham PJ, Gardiner NJ, Wiberg M, Terenghi G. Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage. Glia. 2006;54:840-9.
71. Keilhoff G, Goihl A, Langnas e K, Fansa H, Wolf G. Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. Eur J Cell Biol. 2006;85:11-24.
72. Zhao L, Wei X, Ma Z, Feng D, Tu P, Johnstone BH, et al. Adipose stromal cells-conditional medium protected glutamate-induced CGNs neuronal death by BDNF. Neurosci Lett. 2009;452:238-40.
73. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm- Grove CJ, Bovenkerk JE, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292-8.
74. di Summa PG, Kingham PJ, Raffoul W, Wiberg M, Terenghi G, Kalbermatten DF. Adipose-derived stem cells enhance peripheral nerve regeneration. J Plast Reconstr Aesthet Surg. 2010;63:1544-52.
75. Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffl er C, Dohan SL, et al. Platelet-rich fi brin (PRF): a second- generation platelet concentrate. IV. Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:e56-60.
76. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest. 1987;57:673-86.
77. Cherubino M, Rubin JP, Miljkovic N, Kelmendi-Doko A, Marra KG. Adipose-derived stem cells for wound healing applications. Ann Plast Surg. 2011;66:210-5.
78. Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, et al. In vivo characterization of bone marrow-derived fi broblasts recruited into fi brotic lesions. Stem Cells. 2005;23:699-706.
79. D eng W, Han Q, Liao L, Li C, Ge W, Zhao Z, et al. Engrafted bone marrow-derived fi k-(1 - ) mesenchymal stem cells regenerate skin tissue. Tissue Eng. 2005;11:110-19.
80. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S. Fibrocytes contribute to the myofi broblast population in wounded skin and originate from the bone marrow. Exp Cell Res. 2005;304:81-90.
81. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol. 2001;69:513-21.
82. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007;9:204.
83. Fu X, Li H. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions. Cell Tissue Res. 2009;335:317-21.
84. Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004;22:812-22.
85. Kim WS, Park BS, Sung JH, Yang JM, Park SB, Kwak SJ, et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fi broblasts. J Dermatol Sci. 2007;48:15-24.
86. Branski LK, Gauglitz GG, Herndon DN, Jeschke MG. A review of gene and stem cell therapy in cutaneous wound healing. Burns. 2009;35:171-8.
87. Rossiter H, Barresi C, Pammer J, Rendl M, Haigh J, Wagner EF, et al. Loss of vascular endothelial growth factor a activity in murine epidermal keratinocytes delays wound healing and inhibits tumor formation. Cancer Res. 2004;64:3508-16.
88. Deodato B, Arsic N, Zentilin L, Galeano M, Santoro D, Torre V, et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther. 2002;9: 777-85.
89. Ebrahimian TG, Pouzoulet F, Squiban C, Buard V, Andr M, Cousin B, et al. Cell therapy based on adipose tissuederived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol. 2009;29:503-10.
90. Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil. 2005;26:306-19.
91. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Effi cacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 1998;7:335-46.
92. Lynch SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci USA. 1987;84:7696-700.
93. Marston WA, Hanft J, Norwood P, Pollak R, Dermagraft Diabetic Foot Ulcer Study Group. The effi cacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003;26:1701-5.
94. Cross K, Mustoe T. Growth factors in wound healing. Surg Clin North Am. 2003;83:531-45.
95. Blanton MW, Hadad I, Johnstone BH, Mund JA, Rogers PI, Eppley BL, et al. Adipose stromal cells and plateletrich plasma therapies synergistically increase revascularization during wound healing. Plast Reconstr Surg. 2009;123:56S-64S.
96. Ravari H, Hamidi-Almadari D, Salimifar M, Bonakdaran S, Parizadeh MR, Koliakos G. Treatment of non-healing wounds with autologous bone marrow cells, platelets, fi brin glue and collagen matrix. Cytotherapy. 2011;13: 705-11.
97. Garca-Olmo D, Garca-Arranz M, Herreros D, Pascual I, Peiro C, Rodr guez-Montes JA. A phase I clinical trial of the treatment of Crohn ' s fi stula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48: 1416-23.
98. Garc a-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fi stula: a phase II clinical trial. Dis Colon Rectum. 2009;52:79-86.
99. Garca-Arranz M, Gm ez-Pinedo U, Hardisson D, Herreros D, Guadalajara H, Garc a-G mez I, et al. Histopathological analysis of human specimens removed from the injection area of expanded adipose-derived stem cells. Histopathology. 2010;56:979-82.
100. Varma MJ, Breuls RG, Schouten TE, Jurgens WJ, Bontkes HJ, Schuurhuis GJ, et al. Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cells Dev. 2007;16:91-104.
101. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402-16.
102. Oedayrajsingh-Varma MJ, van Ham SM, Knippenberg M, Helder MN, Klein-Nulend J, Schouten TE, et al. Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 2006;8:166-77.
103. Festy F, Hoareau L, Bes-Houtmann S, Pequin AM, G onthier MP, Munstun A, et al. Surface protein expression between human adipose tissue-derived stromal cells and mature adipocytes. Histochem Cell Biol. 2005;124:113-21.
104. Dicker A, Le Blanc Kastr m G, van Harmelen V, Gt herstr m C, Blomqvist L, et al. Functional studies of mesenchymal stem cells derived from adult human adipose tissue. Exp Cell Res. 2005;308:283-90.